Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results

1mon ago, source: Business Insider

About Xenetic Biosciences Xenetic Biosciences, Inc. is a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard to treat cancers. The Company's ...

Xenetic Biosciences Inc XBIO

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Xenetic Biosciences Inc XBIO

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results

1mon ago, source: Charlotte Observer

FRAMINGHAM, MA / ACCESSWIRE / March 22, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology ...

Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results

1mon ago, source: Kansas City Star

The Company ended the year with approximately $9.0 million of cash. Xenetic Biosciences, Inc. is a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing ...

Xenetic Biosciences Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Xenetic Biosciences Inc (XBIO)

17d ago, source: Investing

Investing.com – U.S. stocks were lower after the close on Friday, as losses in the Consumer Services, Oil & Gas and Utilities sectors led shares lower. At the close in NYSE, the ...